Adaptive Biotechnologies Corp
ADPT
DELAYED 1 MONTH

29 insider filings · Latest: Jul 21, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 21, 2026Jul 23 11:34 PMHarlan S RobinsChief Scientific Officer
Sale
492,400$21.89$10.8M812,058(D)

View →

Jun 4, 2026Jun 9 12:29 AMFrancis LOChief People Officer
Sale
39,741$17.49$695.1K250,934(D)

View →

Jun 4, 2026Jun 9 12:27 AMSusan BobulskyChief Commercial Officer, MRD
Sale
11,000$18.00$198.0K416,775(D)

View →

May 18, 2026May 20 11:13 PMKyle PiskelChief Financial Officer
Sale
3,115$13.04$40.6K256,725(D)

View →

Mar 13, 2026Mar 14 1:36 AMJulie RubinsteinPresident and COO
Sale
19,060$12.96$247.0K507,934(D)

View →

Mar 12, 2026Mar 14 1:36 AMJulie RubinsteinPresident and COO
Sale
19,060$12.86$245.0K512,272(D)

View →

Mar 11, 2026Mar 14 1:36 AMJulie RubinsteinPresident and COO
Sale
141,583$13.29$1.9M516,610(D)

View →

Mar 11, 2026Mar 14 1:05 AMMichelle Renee GriffinDirector
Sale
15,394$13.91$214.1K15,625(D)

View →

Mar 11, 2026Mar 14 1:02 AMFrancis LOChief People Officer
Sale
30,593$14.08$430.7K291,374(D)

View →

Mar 11, 2026Mar 14 12:59 AMSusan BobulskyChief Commercial Officer, MRD
Sale
41,338$13.17$544.4K427,775(D)

View →

Mar 11, 2026Mar 14 12:55 AMSharon BenzenoChief Commercial Ofc Imm Med
Sale
63,103$13.17$831.1K272,751(D)

View →

Mar 11, 2026Mar 14 12:52 AMKyle PiskelChief Financial Officer
Sale
18,672$13.17$245.9K259,840(D)

View →

Mar 11, 2026Mar 14 12:49 AMHarlan S RobinsChief Scientific Officer
Sale
470,266$13.17$6.2M1,522,058(D)

View →

Mar 11, 2026Mar 14 12:45 AMChad M RobinsDirector, CEO and Chairman
Sale
470,167$13.17$6.2M2,301,113(D)

View →

Mar 10, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Sale
19,460$14.68$285.7K643,471(D)

View →

Mar 9, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Sale
30,941$14.79$457.6K647,809(D)

View →

Mar 6, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Sale
30,941$15.14$468.4K652,147(D)

View →

Mar 5, 2026Mar 10 12:29 AMFrancis LOChief People Officer
Sale
38,074$15.09$574.5K321,967(D)

View →

Mar 3, 2026Mar 6 1:05 AMMichelle Renee GriffinDirector
Sale
48,044$15.30$735.1K15,394(D)

View →

Mar 5, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Sale
30,941$16.00$495.1K575,235(D)

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 21, 2026Jul 23 11:34 PMHarlan S RobinsChief Scientific Officer
Option Exercise
284,800$6.550(D)

View →

Jun 4, 2026Jun 9 12:29 AMFrancis LOChief People Officer
Option Exercise
19,521$12.14140,648(D)

View →

Mar 13, 2026Mar 14 1:36 AMJulie RubinsteinPresident and COO
Option Exercise
14,722$6.5562,827(D)

View →

Mar 12, 2026Mar 14 1:36 AMJulie RubinsteinPresident and COO
Option Exercise
14,722$6.5577,549(D)

View →

Mar 11, 2026Mar 14 1:36 AMJulie RubinsteinPresident and COO
Option Exercise
14,722$6.5592,271(D)

View →

Mar 10, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
15,122$12.14403,539(D)

View →

Mar 9, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14403,939(D)

View →

Mar 6, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14415,820(D)

View →

Mar 3, 2026Mar 6 1:05 AMMichelle Renee GriffinDirector
Option Exercise
48,044$3.990(D)

View →

Mar 5, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14427,701(D)

View →

Mar 4, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14439,582(D)

View →

Mar 3, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14451,463(D)

View →